TIA HESKETT: Open Payments
NPI 1487249306 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 28 payments from 11 companies in 2025. Trend: 2023 $243 · 2024 $371 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Amgen Inc. | 5 | $78 |
| Novo Nordisk Inc | 3 | $69 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Dexcom, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $36 |
| ABBVIE INC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Lundbeck LLC | 1 | $15 |
Products named: REXULTI, Ozempic, TRELEGY ELLIPTA, OTEZLA, Dexcom G6 Transmitter, MOUNJARO, VRAYLAR, ENFLONSIA.
Industry payments across MO — which companies pay providers there.
